Functionalized immunostimulating complexes with protein A via lipid vinyl sulfones to deliver cancer drugs to trastuzumab-resistant HER2-overexpressing breast cancer cells

BACKGROUND: Around 20%–30% of breast cancers overexpress the proto-oncogene human epidermal growth receptor 2 (HER2), and they are characterized by being very invasive. Therefore, many current studies are focused on testing new therapies against tumors that overexpress this receptor. In particular,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Nanomedicine
Principais autores: Rodríguez-Serrano, Fernando, Mut-Salud, Nuria, Cruz-Bustos, Teresa, Gomez-Samblas, Mercedes, Carrasco, Esther, Garrido, Jose Manuel, López-Jaramillo, F Javier, Santoyo-Gonzalez, Francisco, Osuna, Antonio
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5034911/
https://ncbi.nlm.nih.gov/pubmed/27698563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S112560
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados